Aging does not impact safety and efficacy of biologic or targeted synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis

Aging does not impact safety and efficacy of biologic or targeted synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis

Abstract Background The study compared biologic (b) and targeted synthetic (ts) disease-modifying antirheumatic drugs (DMARDs) efficacy and safety in elderly rheumatoid arthritis (RA) patients over a period of 1 year. Results This retrospective study included 52 RA patients. At baseline elderly pati...

Full description

Saved in:
Bibliographic Details
Main Authors: Yasemin Tombak, Ajda Bal, Emel Eksioglu, Nihan Abidin, Ozgur Zeliha Karaahmet, Deniz Dulgeroglu
Format: Article
Language:English
Published: SpringerOpen 2025-06-01
Series:Egyptian Rheumatology and Rehabilitation
Subjects:
bDMARDs
Elderly
EULAR
HAQ
Rheumatoid arthritis
Safety of DMARDs
Online Access:https://doi.org/10.1186/s43166-025-00336-2
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items